Changing Treatments

Meet Your Guide
photo of toc promo image
Ruth Fein Revell
Advocate

Writer Ruth Fein Revell interviews world-renowned cancer specialists. It’s a subject she’s all too familiar with, having been diagnosed with a myeloproliferative neoplasm (MPN) more than 25 years ago, which progressed to myelofibrosis. The New Yorker and mother of two is also a rare disease advocate.

Show Sources

SOURCES:

Ruth Fein Revell.

American Cancer Society: “How Treatment Is Planned and Scheduled.”

National Comprehensive Care Network: “NCCN Guidelines for Patients: Myeloproliferative Neoplasms.”